Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis
- 5 October 2005
- journal article
- case report
- Published by Wiley in Arthritis Care & Research
- Vol. 53 (5) , 788-791
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Tumour necrosis factor α inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patientsAnnals of the Rheumatic Diseases, 2004
- Suppression of collagen‐induced arthritis by natural killer T cell activation with OCH, a sphingosine‐truncated analog of α‐galactosylceramideArthritis & Rheumatism, 2004
- Successful tumor necrosis factor α blockade treatment in therapy‐resistant sarcoidosisArthritis & Rheumatism, 2003
- Tumour Necrosis Factor in Sarcoidosis and its Potential for Targeted TherapyBioDrugs, 2003
- Sarcoidosis: immunopathogenetic concepts and their clinical applicationEuropean Respiratory Journal, 1998
- Increased secretion of tumor necrosis factor-alpha, interleukin-1-beta, and interleukin-6 by alveolar macrophages from patients with sarcoidosisJournal of Allergy and Clinical Immunology, 1993